Target intelligence / Profile preview

Endometrial microbiota

Molecular classification
Other (Microbiome)
01

Overview

The endometrial microbiota refers to the community of microorganisms residing within the uterine cavity, which was historically considered sterile but is now recognized to harbor a low-biomass, distinct microbial population (Moreno et al., 2016). Dominated primarily by Lactobacillus species in healthy states, this microbiota plays a crucial role in maintaining a receptive environment for embryo implantation and protecting against pathogenic colonization through the production of lactic acid and antimicrobial peptides (Baker et al., 2018). Dysbiosis, characterized by a shift from Lactobacillus dominance to a high-diversity state containing anaerobic pathogens, is strongly associated with reproductive failures, chronic endometritis, and gynecological cancers (Cicinelli et al., 2018). Therapeutic interventions targeting the endometrial microbiota include the use of targeted antibiotics to clear infections and probiotics to restore a favorable microbial balance, thereby improving clinical outcomes in assisted reproductive technologies (Simon et al., 2019). Furthermore, the composition of the uterine microbiome is being investigated as a potential biomarker for the early detection of endometrial malignancies (Walsh et al., 2019).

Other names
Uterine microbiotaEndometrial microbiomeUterine microbiome
02

Mechanism of action

Restoration of microbial eubiosis, competitive inhibition of pathogenic bacteria, and modulation of local inflammatory cytokine profiles

03

Biological functions

Immune responsePathogen exclusionEpithelial barrier maintenanceReproductive success
04

Disease associations

InfertilityChronic endometritisEndometriosisEndometrial cancerRecurrent pregnancy loss
05

Safety considerations

Risk of secondary dysbiosisAntibiotic resistanceLack of standardized probiotic strainsPotential for opportunistic infections
06

Interacting drugs

Lactobacillus-based probiotics

4 more in the full profile.

07

Biomarkers

Lactobacillus abundanceMicrobial diversity (Shannon index)Presence of Atopobium vaginaePresence of Gardnerella vaginalis

Beyond the preview

Go deeper on Endometrial microbiota.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endometrial microbiota.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call